tumor

Earlier in July, Sayour's lab reported a surprising finding: to trigger a strong immune attack on tumors, it was not necessary to target a specific protein within the cancer.

These droplets then act as transcriptional hubs, activating genes that promote tumor growth.

There’s no existing screen for three-fourths of the types of cancers that Galleri found, because Grail’s blood test employs a new technology that finds telltale bits of DNA shed by tumors into the bloodstream.

According to Sayour, the most striking improvements occurred in patients who, based on tumor biology and other factors, were not expected to respond strongly to immunotherapy.

These fatty acids, a defining feature of obesity, appear to drive tumor development.